Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 12, 2022

SELL
$126.46 - $235.05 $733,468 - $1.36 Million
-5,800 Closed
0 $0
Q3 2021

Oct 12, 2021

BUY
$221.9 - $484.47 $1.29 Million - $2.81 Million
5,800 New
5,800 $2.23 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Pensionfund Dsm Netherlands Portfolio

Follow Pensionfund Dsm Netherlands and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pensionfund Dsm Netherlands, based on Form 13F filings with the SEC.

News

Stay updated on Pensionfund Dsm Netherlands with notifications on news.